Bank of New York Mellon’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Bank of New York Mellon's MDT Position: Q2 2026 in Review
Bank of New York Mellon reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $65.2M and leaving 14,694,253 shares worth $1.15B. The position accounts for 0.19% of the portfolio, ranked #96.
Bank of New York Mellon first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.3B in Q4 2020. 1,704 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Bank of New York Mellon held 14,694,253 shares of Medtronic worth $1.15B as of Q2 2026.
- Bank of New York Mellon sold 807,616 Medtronic shares in Q2 2026, an estimated $65.2M.
- Medtronic made up 0.19% of Bank of New York Mellon's portfolio in Q2 2026, its #96 holding.
- Bank of New York Mellon first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Medtronic position peaked at $2.3B in Q4 2020.
- 1,704 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.